Have a personal or library account? Click to login
Severe acute respiratory syndrome coronavirus 2 infection and West Nile encephalitis in a patient with chronic kidney disease Cover

Severe acute respiratory syndrome coronavirus 2 infection and West Nile encephalitis in a patient with chronic kidney disease

Open Access
|Oct 2025

References

  1. World Health Organization. Global vector control response 2017–2030 [cited 2025 Jun 2]. 2017;51 pp. World Health Organization. 2017. Available from: https://www.who.int/publications/i/item/9789241512978.
  2. Crivei LA, Moutailler S, Gonzalez G, Lowenski S, Crivei IC, Porea D, et al. Detection of West Nile Virus Lineage 2 in Eastern Romania and First Identification of Sindbis Virus RNA in Mosquitoes Analyzed using High-Throughput Microfluidic Real-Time PCR. Viruses. 2023;15(1).
  3. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–3.
  4. Johnson N, de Marco MF, Giovannini A, Ippoliti C, Danzetta ML, Svartz G, et al. Emerging Mosquito-Borne Threats and the Response from European and Eastern Mediterranean Countries. Int J Environ Res Public Health. 2018;15(12).
  5. Pachler K, Lebl K, Berer D, Rudolf I, Hubalek Z, Nowotny N. Putative new West Nile virus lineage in Uranotaenia unguiculata mosquitoes, Austria, 2013. Emerg Infect Dis. 2014;20(12):2119–22.
  6. Bondre VP, Jadi RS, Mishra AC, Yergolkar PN, Arankalle VA. West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol. 2007;88:875–84.
  7. Ciota AT. West Nile virus and its vectors. Curr Opin Insect Sci. 2017;22:28–36.
  8. Camp J V., Nowotny N. The knowns and unknowns of West Nile virus in Europe: what did we learn from the 2018 outbreak? Expert Rev Anti Infect Ther. 2020;18(2):145–54.
  9. Kramer LD, Li J, Shi PY. West Nile virus. Lancet Neurol. 2007;6(2):171–81.
  10. Montgomery RR, Murray KO. Risk factors for West Nile virus infection and disease in populations and individuals. Expert Rev Anti Infect Ther. 2015;13(3):317–25.
  11. Pisani G, Cristiano K, Pupella S, Liumbruno GM. West Nile Virus in Europe and Safety of Blood Transfusion. Transfus Med Hemother. 2016;43(3):158–67.
  12. Sambri V, Capobianchi M, Charrel R, Fyodorova M, Gaibani P, Gould E, et al. West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. Clin Microbiol Infect. 2013;19(8):699–704.
  13. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI. West Nile encephalitis epidemic in southeastern Romania. Lancet. 1998;352(9130):767–71.
  14. Popescu CP, Florescu SA, Cotar AI, Badescu D, Ceianu CS, Zaharia M, et al. Re-emergence of severe West Nile virus neuroinvasive disease in humans in Romania, 2012 to 2017-implications for travel medicine. Travel Med Infect Dis. 2018;22:30–5.
  15. Beck NS, Song S, Park T, Hong SH, Jeong-Eun J, Kim KH, et al. Clinical features of COVID-19 among patients with end-stage renal disease on hemodialysis in the context of high vaccination coverage during the omicron surge period: a retrospective cohort study. BMC Nephrol. 2023;24(1):1–9.
  16. Schiuma M, Pezzati L, Ballone E, Borghi B, Osio M, Mattavelli D, et al. Case Report: A Fatal Case of West Nile Virus Meningoencephalomyelitis in a Woman with Systemic Lupus Erythematosus Initially Misdiagnosed as SARS-CoV-2 Infection. Am J Trop Med Hyg. 2021;104(5):1716–8.
  17. Tylicki L, Puchalska-Reglińska E, Tylicki P, Och A, Polewska K, Biedunkiewicz B, et al. Predictors of Mortality in Hemodialyzed Patients after SARS-CoV-2 Infection. J Clin Med. 2022;11(2).
  18. Angel-Korman A, Peres E, Bryk G, Lustig Y, Indenbaum V, Amit S, et al. Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose. Clin Kidney J. 2021;15(2):226–34.
  19. Adwan L, Al-Sadi T, Shawakha S, Al-Shami NA. Clinical outcomes of COVID-19 in hemodialysis patients. Front Med (Lausanne). 2023;10:1281594.
DOI: https://doi.org/10.2478/jccm-2025-0040 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 429 - 434
Submitted on: Jul 9, 2025
Accepted on: Sep 14, 2025
Published on: Oct 31, 2025
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Vince Akos Andrejkovits, Alexandra Ioana Asztalos, Nina Ioana Bodnar, Erzsebet Iringo Zaharia-Kezdi, Anca Meda Vasiesiu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.